Violation Tracker Individual Record
Company:
Salix Pharmaceuticals Inc.
Current Parent Company:
Bausch Health
Penalty:
$54,000,000
Year:
2016
Date:
June 9, 2016
Offense Group:
competition-related offenses
Primary Offense:
kickbacks and bribery
Secondary Offense:
False Claims Act and related
Violation Description:
The settlement resolved claims that Salix violated the federal Anti-Kickback Statute and False Claims Act by using its speaker programs as a mechanism to pay kickbacks to doctors to induce them to prescribe Salix drugs and medical devices that were reimbursed by federal health care programs.
Level of Government:
federal
Action Type:
agency action
Agency:
U.S. Attorney-Southern District of New York
Civil or Criminal Case:
civil
HQ Country of Parent:
Canada
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source of Data:
https://www.justice.gov/usao-sdny/pr/manhattan-us-attorney-announces-54-million-settlement-against-salix-pharmaceuticals (archived copy)
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
